Richard Silver to Antirheumatic Agents
This is a "connection" page, showing publications Richard Silver has written about Antirheumatic Agents.
Connection Strength
0.387
-
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy. Rheumatology (Oxford). 2022 10 06; 61(10):4155-4162.
Score: 0.202
-
Outcome measures in the lung. Rheumatology (Oxford). 2008 Oct; 47 Suppl 5:v48-50.
Score: 0.077
-
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum. 2007 May; 56(5):1676-84.
Score: 0.069
-
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol. 2019 02; 71(2):182-195.
Score: 0.039